Espee International Finechempharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 M
- Revenue Growth %
- Ebitda
- Net Worth 53.83%
- Total Assets 33.05%
About Espee International Finechempharma
Espee International Finechempharma Private Limited (EIFPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 September 2019 (Five years and four months 30 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.00 M.
Jatinbhai Shah and Pinkyben Shah serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290GJ2019PTC110065
- Company No.
110065
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Sep 2019
- Date of AGM
21 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Espee International Finechempharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jatinbhai Shah  | Director | 25-Sep-2019 | Current |
| Pinkyben Shah | Director | 25-Sep-2019 | Current |
Financial Performance of Espee International Finechempharma.
Espee International Finechempharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 53.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Espee International Finechempharma?
In 2020, Espee International Finechempharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rampex Labs Private LimitedJatinbhai Shah is a mutual person
Gliesse Pharmaceuticals Private LimitedJatinbhai Shah is a mutual person
Espee Lifesciences Private LimitedJatinbhai Shah and Pinkyben Shah are mutual person
Salvino Biosciences Private LimitedJatinbhai Shah is a mutual person
- Healthy Life Nutraceuticals Llp
Pinkyben Shah is a mutual person
Charges (Loans)
₹7.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Dec 2024 | Hdfc Bank Limited | ₹7.00 M | Open |
How Many Employees Work at Espee International Finechempharma?
Unlock and access historical data on people associated with Espee International Finechempharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Espee International Finechempharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Espee International Finechempharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.